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Abstract: The availability of devices for cancer biomarker detection at early stages of the disease is one
of the most critical issues in biomedicine. Towards this goal, to increase the assay sensitivity, device
miniaturization strategies empowered by the employment of high affinity protein binders constitute
a valuable approach. In this work we propose two different surface-based miniaturized platforms for
biomarker detection in body fluids: the first platform is an atomic force microscopy (AFM)-based
nanoarray, where AFM is used to generate functional nanoscale areas and to detect biorecognition
through careful topographic measurements; the second platform consists of a miniaturized
electrochemical cell to detect biomarkers through electrochemical impedance spectroscopy (EIS)
analysis. Both devices rely on robust and highly-specific protein binders as aptamers, and were
tested for thrombin detection. An active layer of DNA-aptamer conjugates was immobilized via
DNA directed immobilization on complementary single-stranded DNA self-assembled monolayers
confined on a nano/micro area of a gold surface. Results obtained with these devices were compared
with the output of surface plasmon resonance (SPR) assays used as reference. We succeeded in
capturing antigens in concentrations as low as a few nM. We put forward ideas to push the sensitivity
further to the pM range, assuring low biosample volume (µL range) assay conditions.
Keywords: biosensors; aptamers; AFM; nanoarray; EIS
1. Introduction
The rapid and reliable detection of multiple biomarkers simultaneously in small sample volumes
is increasingly requested in current clinical practice and represents a fundamental step towards
personalized medicine [1]. Nowadays, most of the available diagnostic devices are solid-state based
analytical assays, where a functionalized surface works as the active element for biorecognition.
Site-specific immobilization of multiple active elements on the same surface to probe low biosample
volumes requires miniaturization and is generally technologically demanding, since it entails
successive steps specifically tailored to each biomarker probe.
One promising strategy for multiplexing probe immobilization is DDI (DNA-directed
immobilization) [2–5], where different DNA-conjugated antibodies targeting different biomarkers
are immobilized via Watson-Crick base pairing on surface-tethered complementary DNA sequences.
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However the synthesis of DNA-protein conjugates is quite challenging, requires click-chemistry kits
and careful optimization in order to assure a final construct that is both suitable for immobilization
and preserves the original affinity.
Nucleic acid aptamers can offer a valid alternative to antibodies. Aptamers are oligosequences
selected in vitro to bind a target with high affinity. In particular, they show highly specific binding
activity since aptamer-target interaction is based on three-dimensional folding patterns, resulting in
dissociation constants in the picomolar range. In addition, aptamers, if compared to standard proteins,
show higher stability, and ease of chemical modification. Aptamer production is fully automated,
highly reproducible, and low-cost. Moreover, aptamers are naturally integrable in the context of DDI:
DNA-aptamer constructs are produced simply by adding a surface binding sequence to the aptamer
during oligo-synthesis.
In this paper, we exploited aptamers as the active recognition elements of miniaturized
DNA-based biosensors. We modified aptamers with a DNA tag (cDNA), meant to hybridize to
micron-sized surface-grafted complementary DNA monolayers, to create the desired functional
areas (Figure 1). In particular, we carefully optimized the immobilization strategy to implement
DNA-modified aptamers onto two innovative, DNA-based miniaturized sensor platforms: (i) atomic
force microscopy (AFM)-based nanoarrays, and (ii) electrochemical impedance spectroscopy
(EIS)-based microelectrodes. Both of these platforms have been designed and developed to allow for
the sensitive detection of biomolecules in small sample volumes.
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SAM can be tuned via nanografting, and adjusted to the steric requirements of the biorecognition 
elements. On such active DNA nanospots, the aptamer-cDNA conjugate is then loaded through 
Watson-Crick base-pairing, in a process known as DNA-directed immobilization [9]. On the other 
side, an electrochemical impedance-based biosensor, with a three-electrode design developed in our 
group for the recognition of nucleic acids [11,12], are tested towards protein detection through 
modified aptamers. The working micro-electrode is fully covered by a functional, thiolated, 
single-stranded DNA SAM, on which the aptamer-cDNA conjugate is then loaded via DDI. 
As a proof of principle, in this study we used an extensively-investigated aptamer for thrombin 
(THR) [13] that shows a well-characterized structure and binding properties (KD = 50 nM), confirmed 
by several studies [14,15]. Two constructs were proposed in this regard: a simple design consisting 
of the aptamer region on the 5′ side, extending with the immobilization region complementary to the 
DNA grafted monolayer on the 3′ side (Supplementary Materials, Figure S1a); a second design 
similar to the first one, but containing a hexaethilenglycol-spacer (HEGL) between the two regions to 
improve the functionality of aptamer binding site (Supplementary Materials, Figure S1b). As stated 
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In the case of nanoarrays, we capitalize here on the exploitation of AFM-based lithography,
nanografting [6–8], and AFM topographic imaging in physiological enviro ment successfully
demonstrated in the work of Bano et al. for the detection of multiple proteins in standardized human
serum [9], and succe sively by Bosco and Ganau et al., for the ultimate integration with a devic for
cell sorting, t measure th secretome of f w selected cells [10]. By AFM nanografting we confined
nanospots of thiol-modified single-stranded DNA monolayers insid a bio-repellent, self assembled
monolayer (SAM) of oligoethyleneglycol-terminated alkanethiols. The de sity of the DNA-confi ed
SAM can be tuned via nanografting, and adjusted to the steric requirements of the biorecognition
elements. On such active DNA nanospots, the aptamer-cDNA conjugate is then loaded through
Watson-Crick base-pairing, in a process known as DNA-directed immobilization [9]. On the other side,
an electrochemical impedance-based biosensor, with a three-electrode design developed in our group
for the recognition of nucleic acids [11,12], are tested towards protein detection through modified
aptamers. The working micro-electrode is fully covered by a functional, thiolated, single-stranded
DNA SAM, on which the aptamer-cDNA conjugate is then loaded via DDI.
As a proof of principle, in this study we used an extensively-investigated aptamer for thrombin
(THR) [13] that shows a well-characterized structure and binding properties (KD = 50 nM), confirmed
by several studies [14,15]. Two constructs were proposed in this regard: a simple design consisting of
the aptamer region on the 5′ side, extending with the immobilization region complementary to the
DNA grafted monolayer on the 3′ side (Supplementary Materials, Figure S1a); a second design similar
to the first one, but containing a hexaethilenglycol-spacer (HEGL) between the two regions to improve
the functionality of aptamer binding site (Supplementary Materials, Figure S1b). As stated in several
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works, the use of polyethyleneglycol groups can significantly improve biorecognition sensitivity by
reducing nonspecific interactions and steric hindrance effects [16,17]. In both cases the surface linking
oligo sequence (with an alkanethiol linker to bind to the gold surface), and the complementary one on
the aptamer side, were carefully selected to have minimal influence on the protein binding—aptamer
region in order to avoid possible interferences during aptamer immobilization and then on the aptamer
binding interaction with THR.
2. Materials and Methods
2.1. Preliminary Affinity Characterization of the DNA-Aptamer Constructs
Affinity characterization of the DNA-aptamer constructs was first carried out in silico
using the web service UNAFold, developed by Zucker and his coworkers [18]. The software
application [19] for hybridization of two different oligonucleotide strands was used to
generate temperature-dependent concentration plots of the tested sequence pairs in buffer,
considering an ionic composition of 150 mM Na+, 2 mM Mg2+, similar to the binding
buffer used in further wet experiments. The calculated concentrations from the plot data
for hybridized and free sequences at 25 ◦C were further used to determine the theoretical
dissociation constants (KD). In this regard theoretical KD values were calculated and
compared for the thiolated linker sequence cF9 (5′-CTTCACGATTGCCACTTTCCAC-3′) vs.
the protein binding aptamer sequence (5′-GGTTGGTGTGGTTGG-3′) and the complementary
hybridization region F9 (5′-GTGGAAAGTGGCAATCGTGAAG-3′) used in the aptamer
constructs. The designed aptamer constructs were further tested in bulk conditions for
their functionality, testing the binding affinity for human thrombin (HT) in a qualitative
electrophoretic mobility shift assay (EMSA) (Supplementary Materials). Two different
aptamer constructs were prepared: the one in which the F9 sequence is directly extending
from the aptamer sequence (5′-GGTTGGTGTGGTTGGGTGGAAAGTGGCAATCGTGAAG-3′),
named F9aTHR and with hexaethyleneglycol (HEGL) linker in between,
(5′-GGTTGGTGTGGTTGG-HEGL-GTGGAAAGTGGCAATCGTGAAG-3′), named F9-HEGL-aTHR.
All the reagents in the binding experiments including buffers, human thrombin and materials used for
synthesis of aptamer constructs F9aTHR and F9-HEGL-aTHR, were ordered from Sigma-Aldrich Corp.
(Saint Louis, MO, USA).
To test aptamer affinity on surfaces, a Biacore X100 Surface Plasmon Resonance (GE Healthcare,
Little Chalfont, Buckinghamshire, UK) instrument was used at a constant temperature of 25 ◦C.
A continuous flow (5 µL/min) of PBS buffer (running buffer) was maintained during all the
experiments. First, a biotinilated cF9 sequence (cF9-biotin, 2 µM in PBS buffer) was immobilized
over the Biacore SA gold chip surface. The immobilization through streptavidin-biotin binding was
stopped after reaching a binding level of ~1200 RU, corresponding to an amount of ssDNA on the
surface that ensure an efficient attachment of the molecules in the following steps of the experiment;
then the surface was rinsed with two 1 min pulses of 50 mM NaOH solution, in order to remove
unbound cF9-biotin [20]. The hybridization was carried out by incubation with F9-HEGL-aTHR at
30 µM in TE buffer with 1 M NaCl until reaching a binding level of ~500 RU, to form an active layer
suitable to detect a binding signal also with the lowest concentrations of analyte. The immobilization
procedure was followed by a flow of running buffer for 2 h in order to remove aptamers non-specifically
bound to the surface and to stabilize the baseline. After this procedure the signal remained constant
without any baseline drifting. Binding affinity tests were performed injecting different dilutions of
thrombin (0, 0.2, 0.8, 3.1, 12.5, 50, and 200 nM) in running buffer at a flow rate of 30 µL/min for
3 min (association phase) and afterwards flushing with running buffer for 5 min (dissociation phase).
For the regeneration of the surface 1 min pulses of a 50 mM NaOH solution were used, followed by a
stabilization time of 5 min [21]. Binding affinity parameters were calculated using the BIAevaluation
3.1 software (Biacore GE Healthcare, Little Chalfont, Buckinghamshire, UK).
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2.2. AFM-Based Nanoarrays
All AFM experiments were carried out on a XE-100 Park Instrument (Park System Corp., KANC 4F,
Suwon, Korea) with a customized liquid cell. A tip-assisted AFM-based nanolithography technique has
been used to fabricate DNA nanoarrays with high surface density (1–2 × 1013 molecules/cm2): using
Si cantilevers (NSC36B Mikromasch (Mikromasch, Innovative Solutions Bulgaria Ltd., Sofia, Bulgaria),
spring constant: 0.6 N/m) multiple nanografting assembled monolayers (NAM) of thiol-modified
single-stranded DNA (ssDNA), named cF9, were prepared by serial AFM-based nanografting inside
a self-assembled monolayer (SAM) of a top oligo ethylene glycol terminated alkanethiol, TOEG
((1-mercaptoundec-11-yl)hexa(ethyleneglycol), HS-(CH2)11-(OCH2CH2)6-OH from Sigma Aldrich)
on ultraflat gold surfaces [22] following standard protocols reported earlier [9,23]. The DNA patches
were obtained promoting the replacement of the TOEG molecules with the oligonucleotides by the
AFM tip scanning an area of 1 µm × 1 µm or less at high force (about 100 nN) in the presence of a
solution of thiolated ssDNA sequences (5 µM in TE buffer 1 M NaCl) at a scan rate of 2 Hz. Several
patches (6–8 for each experiment, to guarantee good statistics) of cF9 ssDNA were produced.
Aptamer immobilization was performed via DDI, incubating the ssDNA SAM with 1:1 mix of
F9-HEGL-aTHR and F9 at 2 µM in TE buffer with 1 M NaCl in order to avoid steric hindrance by
reducing the aptamer surface density, hence, preserving the activity.
Aptamer-thrombin binding was promoted through the incubation of aptamer nanopatches for
one hour with a solution (volume of about 100 µL) containing thrombin at different concentrations
(THR buffer: 20 mM Tris pH 7.4, 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2); topographic
height variations over the NAMs were measured with AFM in gentle contact with standard silicon
cantilevers (CSC38 Mikromasch, spring constant: 0.06 N/m) at a 1 Hz scan rate, applying a force of
0.1 nN to detect and quantify binding affinity.
2.3. EIS-Based Devices
Electrochemical impedance spectroscopy (EIS)-based devices were fabricated using optical
lithography techniques. They consist of a three-electrode electrochemical cell with microfabricated
working (WE) and the counter (CE) gold electrodes and a classical mm-sized Ag/AgCl reference
electrode (RE). As in standard electrochemical setup, the potential (AC, 10 mV rms) is applied across
WE and RE, whereas the current is measured across WE and CE. The differential capacitance (Cd)





is obtained by fitting the current response of the device upon application of the AC voltage at four
frequencies: 100 Hz, 200 Hz, 250 Hz, and 400 Hz, by using the HEKA PG340 USB bipotentiostat
(HEKA Elektronik, Dr. Schulze, GmbH, Lambrecht, Germany). As already explained in [11,12], at each
frequency we collect 200 complete periods from which we compute the root mean squared value of the
measured current, Irms = 2pifVrmsCd, and the relative uncertainties using error propagation analysis.
We also proved that the device is reusable up to several times and the data are reproducible on different
sensors with a standard deviation of only a few percent.
Cd variations, recorded upon exposing the electrochemical cell to aptamer-DNA
conjugate/analyte containing solutions, were quantitatively connected to the number of biorecognition
events. In particular, Cd is mostly affected by molecular layer height changes, the replacement of
water molecules in the biological layer, and by electrical charge redistribution upon biorecognition.
Electrodes were first patterned on clean microscope slides using MEGAPOSITTM SPRTM 220 1.2
(Series Photo-Resist) (The Dow Chemical Company, Michigan, USA) as the optical positive resist.
The slides were then metalized in an e-beam evaporator, with a 20-nm Ti layer, in order to promote
the adhesion, followed by 80-nm Au layer deposition and then kept in an acetone bath overnight in
order to perform the lift-off process. After lift-off, the electrodes were coated again with an insulating
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layer of NANOTMSU8-2002 (MicroChem Corp., Westborough, MA, USA), shaped to expose only the
circular part of WE and CE. SU8 was used as insulating material to reduce the active surface area for
biorecognition. The circular WE exposed to the solution, the arc of the CE and the profile of the SU8
layer, which covers the rest of the metal electrodes, are visible in Figure 2.
Chemosensors 2016, 4, 18  5 of 10 
 
insulating layer of NANOTMSU8-2002 (MicroChem Corp., Westborough, MA, USA), shaped to 
expose only the circular part of WE and CE. SU8 was used as insulating material to reduce the active 
surface area for biorecognition. The circular WE exposed to the solution, the arc of the CE and the 
profile of the SU8 layer, which covers the rest of the metal electrodes, are visible in Figure 2. 
 
Figure 2. (a) Sample holder equipped with an electronic card to bring the signal to the 
HEKA-bipotentiostat; (b) microfabricated working and counter gold electrodes (black) on the 
patterned insulation layer (SPR 220 1.2) (pink); and (c) zoom-in of the central part of the electrodes. 
The diameter of the WE in contact with the solution is 100 μm. The patterned resist used to 
electrically insulate the electrodes is clearly recognizable as the darker-gray outer area of the image. 
The insulating SU8-layer had a thickness of about 1.5 μm, measured using a 3D surface 
profilometer. Gold electrode functionalization with ssDNA molecules was carried out using the 
well-established procedures for creating DNA SAMs on gold [24–26]. Initially the electrodes were 
wetted for 15 min with a drop of a high-ionic-strength buffer, TE NaCl 1 M, containing cF9-SH to 
create a low density DNA SAM (2.1 × 1012 molecules/cm2) [12]. Low density monolayers were chosen 
to avoid steric hindrance limitations to the hybridization efficiency. In this regime DNA 
hybridization follows Langmuir-like kinetics [12,27], while electrostatic charges are largely screened 
allowing for fast hybridization kinetics and reducing the limit of detection of the device. After each 
functionalization step the devices were rinsed with the proper DNA/protein buffer solution, prior to 
capacitance measurements. SAM hybridization was performed with 1 μM DNA-aptamer construct in 
about 100 μL solution (same volume as for the nanoarray measurements) containing 100 mM KCl. To 
follow hybridization kinetics, we initially measured at a rate of four measurements/min for 15 min, 
then we slowed down to one measurement/min until the Cd differential variations between 
successive points were lower than 6%, which we considered to be the “steady-state” of our measure. 
3. Results and Discussion 
3.1. Preliminary Affinity Characterization of the DNA-Aptamer Constructs 
All of the experiments were carried out using a buffer (THR buffer) that folds the aptamer in the 
functional conformation for the recognition of the antigen. To this aim, preliminary tests were 
carried out to check that both the affinity of the DNA-aptamer construct for the surface immobilized 
complementary strand and the one for the ligand were preserved. In this regard an estimation of 
hybridization affinity between the thiolated linker and aptamer construct was first performed in silico. 
According to UNAFold analysis, the calculated KD value of cF9-F9aTHR binding in bulk conditions 
resulted to be in the order of magnitude of attomolar, much lower than the KD value obtained for F9 
binding to the aptamer region alone (6.5 μM), therefore, suggesting that the immobilization of the 
DNA-aptamer constructs is occurring essentially through the cF9-F9 pairing. Using EMSA, we also 
verified that both DNA-aptamer constructs were able to bind thrombin (Supplementary Materials, 
Figure S2). However, F9-HEGL-aTHR was observed to bind more efficiently to THR compared to 
F9aTHR, so in the following experiments we decided to focus on the first construct. 
i re 2. (a) Sample holder equipped with an electronic card t ri t e si l t t e
-bi otentiostat; (b) microfabricated working and counter gold electrodes (black) on the patterned
insulation layer (SPR 220 1.2) (pink); and (c) zoom-in of the central part of the electrodes. The diameter
of the WE in contact with the solution is 100 µm. The patterned resist used to electrically insulate the
electrodes is clearly recognizable as the darker-gray outer area of the image.
e i s lati S 8-la er a a t ic ess f a t 1.5 µ , eas re si a 3 s rface
rofilo eter. ol electro e f ctio alizatio it ss olec les as carrie o t si t e
ell-establis e roce res for creati S s o ol [24–26]. I itiall t e electro es ere
ette for 15 min with a drop of a hig -ionic-strength buffer, TE NaCl 1 M, containi g cF9-SH to create
a low density DNA SAM (2.1 × 1012 molecules/cm2) [12]. Low density monolayers were chosen to
avoid steric hindrance limitations to the hybridization efficiency. In this regime DNA hybridization
follows Langmuir-like kinetics [12,27], while electrostatic charges are largely screened allowing for fast
hybridization kinetics and reduci g the limit of detection of the device. After each functionalization
step the devices were rinsed with the proper DNA/protein buffer solution, prior to capacitance
measurements. SAM hybridization was performed with 1 µM DNA-aptamer construct in about
100 µL solution (same volume as for the nanoarray measurements) containing 100 mM KCl. To follow
hybridization kinetics, we initially measured at a rate of four measure ents/min for 15 min, then we
slowed down to one measurement/min until the Cd differential variations between successive points
were lower than 6%, which we considered to be the “steady-state” of our measure.
. Results and iscussion
3.1. Preli inary Affinity Characterization of the A-Apta er Constructs
ll of the experi ents were carried out using a buffer (THR buffer) that folds the aptamer in
the functional conformation for the recognition of the antigen. To this ai , preli inary tests ere
carried out to check that both the affinity of the DNA-apta er construct for the surface i obilized
co ple entary strand and the one for the ligand ere preserved. In this regard an esti ation of
hybridization affinity bet een the thiolated linker and apta er construct as first perfor ed in silico.
ccording to Fold analysis, the calculated value of cF9-F9aT R binding in bulk conditions
resulted to be in the order of agnitude of atto olar, uch lo er than the KD value obtained for F9
binding to the apta er region alone (6.5 µ ), therefore, suggesting that the i obilization of the
-apta er constructs is occurring essentially through the cF9-F9 pairing. sing E S , e also
verified that both -apta er constructs ere able to bind thro bin (Supple entary aterials,
Chemosensors 2016, 4, 18 6 of 10
Figure S2). However, F9-HEGL-aTHR was observed to bind more efficiently to THR compared to
F9aTHR, so in the following experiments we decided to focus on the first construct.
Binding affinity analysis was then performed on surface immobilized aptamers via SPR,
following the DNA-aptamer immobilization procedure described in the previous session. A wide THR
concentration range (0.8–200 nM) was screened with Biacore. The signal response is proportional to
the THR concentration (Figure 3a); the mostly straight binding lines in the association phase obtained
with analyte injections up to 12.5 nM show a possible mass transfer contribution. These curves do not
display a sufficient curvature to perform kinetic analysis. Although an equilibrium state has not been
reached for all the concentrations tested, we recorded the binding level at the end of the association
phase. These values, plotted against THR concentration, were fitted with a single site interaction
model. This “non-steady-state” analysis implies an underestimation of the binding affinity [28,29].
Therefore, we can conclude from the SPR data that the KD is in the range 10–100 nM, in agreement
with the value reported in the literature for the aptamer-THR binding (KD = 50 nM) (Figure 3b).
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Figure 4. I ages of the nanopatches on the gold surface (left, bar 1 µm) and their topographic profiles
(right). Black: F9-HEGL-aT R aptamer immobilization; red: THR 12 nM incubation; and green: THR
1000 nM incubation.
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By using AFM topographic imaging, we monitored height profile changes over DNA-aptamers
loaded by DDI on cF9 nanografted arrays (Figure 4: left, upper patches; right, black profile) vs. different
THR concentrations in the binding buffer (Figure 4 left, mid and lower images; Figure 4 right, red and
green profiles correspond to 12 nM and 1000 nM THR, respectively), due to the conformation change of
the aptamer upon binding the ligand. In all these steps the TOEG SAM embedding the patches is used
as a reference level to monitor topographic height changes [9]. Differential height changes are shown in
Figure 5a. By plotting height change vs. concentration, we extracted an effective dissociation constant
for this system in the range 10–100 nM, a value that is in good agreement both with literature and with
the SPR results obtained using the same molecular construct. As one can clearly see in Figure 5a, the
data are affected by significantly large errors that could be attributed to the fact that when the ligand
binds to the aptamer, it folds to a more compact shape.
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This results in a reduced AFM differential height, since the height increase due to protein uptake
is counterbalanced by the height decrease due to a change in binder conformation. Additionally,
the softness of the nanopatches contributes to such large errors: the coupling of the aptamer to the
nucleic acid linker, in fact, increases the compressibility of the entire nanopatch, giving more variability
while measuring AFM height variation [30]. We then performed a so-called “compressibility analysis”:
we monitored the softness of the patches, exposed to different THR concentrations, by imaging
progressively the patches at increased tip load. The variation of (absolute) patch height vs. tip load for
the bare DNA patches, the patches loaded with the aptamer constructs and then the last ones exposed
to different THR concentrations are shown in Figure 5b. As shown in Figure 5b, while applying only
200 pN, nanopatches can be compressed up to 40% of the height measured at minimum force (about
50 pN below which the AFM tip loss its contact with the surface). However, from such analysis we
can conclude that the higher the THR concentration, the stiffer the patch towards tip compression.
The increase of nanopatch stiffness upon THR immobilization is due to the high compactness of
globular proteins (as THR), much higher than for nucleic acids at the ionic strength used for the
experiments. A stiffness change of about 30%–35% upon 4 nM THR binding can, in fact, be estimated
from the compressibility experiments, at variance with the patch height that stays almost constant.
3.3. EIS on Self Assembled Monolayers
Finally we performed an EIS analysis of the DNA-aptamer construct binding. First we checked the
stability of the DNA-aptamer SAM-covered electrode in KCl buffer solution (Figure 6a, in orange); then,
we changed the buffer with the one for THR, which contains divalent ions. The capacitance-change
kinetics measured in-situ upon changing of the buffer solution (Figure 6a, in cyan) has to be attributed
to the electrode interface rearrangement caused by the conformational reorganization of the nucleic
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acids upon the interaction with the divalent salt solution. At this point, after stabilization, we
challenged the device for thrombin detection. In particular, we monitored the capacitance response
to three different THR concentrations, on the same device, regenerating it (using a solution with
2 M NaCl) after each test. The capacitance variation upon binding of 4 nM THR is shown in green.
After regeneration, we tested again the stability of the aptamer-functionalized electrode (in black) and
incubated the sensor with a solution with a 40 nM thrombin (in blue). We compared the maximum
capacitance variation between the two equilibrium states at different concentration (4, 10 and 40 nM)
by the EIS sensor obtaining 12.3% ± 3.9%, 21.1% ± 3.3%, and 44.9% ± 2.7% respectively, in very good
agreement with SPR data (Figure 6b).
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The height change measurements on the nanoarrays, moreover, can be combined with the monitoring
of roughness variations on the patch and outside it to infer the occurrence of specific binding only on
the patch, and exclude the presence of aspecific binding outside it, even without the use of (expensive)
sandwich schemes.
We put forward the idea to complement our data with AFM-based force spectroscopy
measurements to investigate the variation of the mechanical properties of the DNA-aptamer conjugate
structures upon ligand binding. This additional strategy might be particularly profitable given
the peculiar properties of aptamers, which undergo a global conformational change upon binding.
Furthermore, combining the output of these two techniques, a structural-mechanical model for the
interface may be derived to be, in turn, used to describe the details of capacitance changes at the
gold electrode.
Supplementary Materials: The following are available online at www.mdpi.com/2227-9040/4/3/18/s1.
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